{
    "id": 2406,
    "fullName": "AR H875Y",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "AR H875Y (also referred to as H874Y) lies within the C-terminal ligand binding domain of the Ar protein (PMID: 22403669). H875Y confers a gain of function to the Ar protein as demonstrated by constitutive activation of Ar and activation in the presence of anti-androgens in cell culture (PMID: 22403669, PMID: 9092797, PMID: 26760770).",
            "references": [
                {
                    "id": 673,
                    "pubMedId": 22403669,
                    "title": "The impact of point mutations in the human androgen receptor: classification of mutations on the basis of transcriptional activity.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22403669"
                },
                {
                    "id": 6008,
                    "pubMedId": 9092797,
                    "title": "Dehydroepiandrosterone activates mutant androgen receptors expressed in the androgen-dependent human prostate cancer xenograft CWR22 and LNCaP cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/9092797"
                },
                {
                    "id": 11247,
                    "pubMedId": 26760770,
                    "title": "BAY 1024767 blocks androgen receptor mutants found in castration-resistant prostate cancer patients.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26760770"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 367,
        "geneSymbol": "AR",
        "terms": [
            "AR",
            "AIS",
            "AR8",
            "DHTR",
            "HUMARA",
            "HYSP1",
            "KD",
            "NR3C4",
            "SBMA",
            "SMAX1",
            "TFM"
        ]
    },
    "variant": "H875Y",
    "createDate": "10/23/2014",
    "updateDate": "12/10/2018",
    "referenceTranscriptCoordinates": {
        "id": 146191,
        "transcript": "NM_000044",
        "gDna": "chrX:g.67723701C>T",
        "cDna": "c.2623C>T",
        "protein": "p.H875Y",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 2386,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, BMS-641988 inhibited tumor growth in a xenograft model of prostate cancer harboring AR H875Y (also reported as H874Y) (PMID: 19654297).",
            "molecularProfile": {
                "id": 2290,
                "profileName": "AR H875Y"
            },
            "therapy": {
                "id": 2819,
                "therapyName": "BMS-641988",
                "synonyms": null
            },
            "indication": {
                "id": 10283,
                "name": "prostate cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 3018,
                    "pubMedId": 19654297,
                    "title": "Discovery of BMS-641988, a novel and potent inhibitor of androgen receptor signaling for the treatment of prostate cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19654297"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 2385,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, cells expressing AR H875Y (also reported as H874Y) demonstrated resistance to Nilandron (nilutamide) in culture, via a switch of Nilandron (nilutamide) from androgen receptor antagonist to agonist (PMID: 9815822).",
            "molecularProfile": {
                "id": 2290,
                "profileName": "AR H875Y"
            },
            "therapy": {
                "id": 1506,
                "therapyName": "Nilutamide",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 776,
                    "pubMedId": 9815822,
                    "title": "Functional characterization of mutant androgen receptors from androgen-independent prostate cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/9815822"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 4929,
            "approvalStatus": "Clinical Study - Cohort",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical study, seven metastatic castration-resistant prostate cancer patients with AR H875Y (reported as H874Y) or T878A (reported as T877A) detected in cell-free DNA had progressed on or had received prior treatment with Zytiga (abiraterone) (PMID: 25712683).",
            "molecularProfile": {
                "id": 2290,
                "profileName": "AR H875Y"
            },
            "therapy": {
                "id": 1805,
                "therapyName": "Abiraterone",
                "synonyms": null
            },
            "indication": {
                "id": 10283,
                "name": "prostate cancer",
                "source": "DOID"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 4735,
                    "pubMedId": 25712683,
                    "title": "Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25712683"
                }
            ],
            "ampCapAscoEvidenceLevel": "C",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 2290,
            "profileName": "AR H875Y",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 146191,
            "transcript": "NM_000044",
            "gDna": "chrX:g.67723701C>T",
            "cDna": "c.2623C>T",
            "protein": "p.H875Y",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}